Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of Guelph

$42,450.00

Towards the development of a vaccine for control of avian influenza virus infection in chickens

FY 2009-10

Summary
Avian influenza virus (AIV) is a disease-causing virus, which is of great importance to human and poultry health. This virus has already caused significant economic damage to the Canadian poultry industry. During the recent epidemic of AIV in the Fraser Valley, BC, over 17 million chickens were culled. In addition to its impact on viability of the global poultry industry, there are human health concerns associated with epidemics of highly pathogenic AIV. There have been several reports of transmission of the virus from birds to humans in East Asia, Turkey, and Africa. Although human-to-human transmission of the virus is suspected to be extremely rare at this time, the pandemic flu virus will have gained the ability to transmit from infected humans to other individuals. Several strategies may be envisaged for control of AIV in chickens and its transmission to humans. Among these strategies, vaccination is of importance. A suitable vaccine will not only prevent infected chickens from showing clinical signs of disease, but it will also help control virus shedding from the infected birds. This will have an impact on the ability of the virus to spread to other animals and possibly to human populations. Thus, the proposed studies seek to: 1- design a vaccine formulation with superior ability to elicit protective responses in chickens; 2- test various compounds to further enhance the ability of this vaccine formulation to induce immune response and reduce virus shedding; 3- elucidate the immunological correlates of protection against AIV in chickens. It is expected that the findings of the proposed studies will enhance our knowledge of chicken immunity against AIV and, more importantly, will lead to the development of an efficacious and rational vaccine for control of AIV infection in chickens.
Program
Collaborative Research and Development Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
379624-2008
Name nom
Sharif, Shayan
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2008
Award amount
42450
Program id
CRDPJ
Program nane en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
2
Application title
Towards the development of a vaccine for control of avian influenza virus infection in chickens
Keyword
NA
Application summary
Avian influenza virus (AIV) is a disease-causing virus, which is of great importance to human and poultry health. This virus has already caused significant economic damage to the Canadian poultry industry. During the recent epidemic of AIV in the Fraser Valley, BC, over 17 million chickens were culled. In addition to its impact on viability of the global poultry industry, there are human health concerns associated with epidemics of highly pathogenic AIV. There have been several reports of transmission of the virus from birds to humans in East Asia, Turkey, and Africa. Although human-to-human transmission of the virus is suspected to be extremely rare at this time, the pandemic flu virus will have gained the ability to transmit from infected humans to other individuals. Several strategies may be envisaged for control of AIV in chickens and its transmission to humans. Among these strategies, vaccination is of importance. A suitable vaccine will not only prevent infected chickens from showing clinical signs of disease, but it will also help control virus shedding from the infected birds. This will have an impact on the ability of the virus to spread to other animals and possibly to human populations. Thus, the proposed studies seek to: 1- design a vaccine formulation with superior ability to elicit protective responses in chickens; 2- test various compounds to further enhance the ability of this vaccine formulation to induce immune response and reduce virus shedding; 3- elucidate the immunological correlates of protection against AIV in chickens. It is expected that the findings of the proposed studies will enhance our knowledge of chicken immunity against AIV and, more importantly, will lead to the development of an efficacious and rational vaccine for control of AIV infection in chickens.